Last Updated：2025/11/25
Sentence
最近の第II相試験で、開発中のヒト化モノクローナル抗体は再発した非ホジキンリンパ腫患者で有望な奏効を示しました。
Quizzes for review
In a recent phase II study, dacetuzumab demonstrated encouraging responses in patients with relapsed non-Hodgkin lymphoma.
See correct answer
In a recent phase II study, dacetuzumab demonstrated encouraging responses in patients with relapsed non-Hodgkin lymphoma.
音声機能が動作しない場合はこちらをご確認ください
Related words
dacetuzumab
IPA(Pronunciation)
English - English
Word Edit Setting
- Users who have edit permission for words - All Users
- Screen new word creation
- Screen word edits
- Screen word deletion
- Screen the creation of new headword that may be duplicates
- Screen changing entry name
- Users authorized to vote on judging - Editor
- Number of votes required for decision - 1
Sentence Edit Setting
- Users who have edit permission for sentences - All Users
- Screen sentence deletion
- Users authorized to vote on judging - Editor
- Number of votes required for decision - 1
Quiz Edit Setting
- Users who have edit permission for quizzes - All Users
- Users authorized to vote on judging - Editor
- Number of votes required for decision - 1
